Acute respiratory failure is a frequent cause of hospitalizations among seriously ill older adults at or near the end of life. These terminal hospitalizations are often complicated by distressful respiratory symptoms and chaotic transitions that result in high-intensity, high-risk interventions such as invasive mechanical ventilation (IMV) and noninvasive ventilation (NIV), which delivers positive pressure ventilation through a mask. In this issue of JAMA Internal Medicine, Sullivan and colleagues1 studied trends in IMV and NIV use among older decedents hospitalized at the end of life. The authors found a substantial increase in NIV use and a slight increase in IMV use in the past 2 decades, potentially signifying a major shift in the way that clinicians provide ventilatory support at the end of life. Although use of NIV in older adults with terminal respiratory failure may seem appealing, high-quality evidence supporting its use across serious illnesses remains elusive.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Iyer AS. Noninvasive Ventilation in Seriously Ill Older Adults at the End of Life—The Evidence Remains Elusive. JAMA Intern Med. 2021;181(1):102–103. doi:10.1001/jamainternmed.2020.5648
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: